Home › Compare › ARSUF vs SBUX

ARSUF vs SBUX: Dividend Comparison 2026

ARSUF yields 1.45% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARSUF wins by $17.03M in total portfolio value· pulled ahead in Year 3
10 years
ARSUF
ARSUF
● Live price
1.45%
Share price
$27.00
Annual div
$0.39
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$17.20M
Annual income
$15,185,781.50
Full ARSUF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — ARSUF vs SBUX

📍 ARSUF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARSUFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARSUF + SBUX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ARSUF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARSUF
Annual income on $10K today (after 15% tax)
$123.09/yr
After 10yr DRIP, annual income (after tax)
$12,907,914.28/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, ARSUF beats the other by $12,847,448.29/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARSUF + SBUX for your $10,000?

ARSUF: 50%SBUX: 50%
100% SBUX50/50100% ARSUF
Portfolio after 10yr
$8.68M
Annual income
$7,628,458.98/yr
Blended yield
87.85%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ARSUF
No analyst data
Altman Z
3.9
Piotroski
7/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARSUF buys
0
SBUX buys
0
No recent congressional trades found for ARSUF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARSUFSBUX
Forward yield1.45%2.84% ✓
Annual dividend / share$0.39$2.46 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100% ✓48.3%
Portfolio after 10y$17.20M$167.0K ✓
Annual income after 10y$15,185,781.50 ✓$71,136.45
Total dividends collected$17.02M$136.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: ARSUF vs SBUX ($10,000, DRIP)

YearARSUF PortfolioARSUF Income/yrSBUX PortfolioSBUX Income/yrGap
1$10,990$289.63$11,121$420.68$131.00 → SBUX
2$12,354$594.94$12,548$648.40$194.00 → SBUX
3← crossover$14,469$1,250.08$14,440$1,013.98+$29.00 → ARSUF
4$18,218$2,736.60$17,068$1,617.30+$1.1K → ARSUF
5$25,934$6,440.67$20,912$2,649.52+$5.0K → ARSUF
6$44,887$17,137.37$26,875$4,499.29+$18.0K → ARSUF
7$103,471$55,441.98$36,771$8,014.12+$66.7K → ARSUF
8$349,596$238,882.57$54,542$15,197.11+$295.1K → ARSUF
9$1,882,687$1,508,619.21$89,602$31,242.49+$1.79M → ARSUF
10$17,200,257$15,185,781.50$167,011$71,136.45+$17.03M → ARSUF

ARSUF vs SBUX: Complete Analysis 2026

ARSUF — Stock

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Full ARSUF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ARSUF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARSUF vs SCHDARSUF vs JEPIARSUF vs OARSUF vs KOARSUF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.